Ustekinumab in Infliximab-refractory Pediatric UC Ustekinumab in Infliximab-refractory Pediatric UC
This study evaluated the efficacy of ustekinumab following failure of prior biologics in pediatric ulcerative colitis.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 23, 2021 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
Crohn ’s Disease vs Ulcerative Colitis Difference
Crohn ’s Disease vs. Ulcerative Colitis: What ' s the Difference? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 21, 2021 Category: General Medicine Source Type: news
What Is Life Expectancy with Ulcerative Colitis
What Is the Life Expectancy with Ulcerative Colitis? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 18, 2021 Category: General Medicine Source Type: news
What Is the Best Treatment for Ulcerative Colitis
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 18, 2021 Category: General Medicine Source Type: news
What Were First Symptoms of Ulcerative Colitis
What Were Your First Symptoms of Ulcerative Colitis? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 17, 2021 Category: General Medicine Source Type: news
What Is the Life Expectancy of Ulcerative Colitis
What Is the Life Expectancy of Someone with Ulcerative Colitis? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 17, 2021 Category: General Medicine Source Type: news
COVID Vaccines Appear Safe for People With IBD
THURSDAY, June 10, 2021 -- The Pfizer and Moderna COVID-19 vaccines appear to be safe for people with inflammatory bowel diseases (IBD), a new study finds.
IBDs -- which includes Crohn ' s disease and ulcerative colitis -- are chronic conditions... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 10, 2021 Category: General Medicine Source Type: news
FDA Approves Ozanimod (Zeposia) for Ulcerative Colitis FDA Approves Ozanimod (Zeposia) for Ulcerative Colitis
Once-daily, oral ozanimod is the first sphingosine-1-phosphate receptor modulator approved for adults with moderately to severely active ulcerative colitis.FDA Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - May 28, 2021 Category: Drugs & Pharmacology Tags: Gastroenterology News Alert Source Type: news
'Good' bacteria show promise for clinical treatment of Crohn's disease, ulcerative colitis
(University of North Carolina Health Care) Balfour Sartor, MD, Midget Distinguished Professor of Medicine, Microbiology and Immunology, is the senior author of a study that shows how a novel consortium of bacteria that live in the digestive tracts of healthy individuals can be used to prevent and treat aggressive colitis in humanized mouse models. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 28, 2021 Category: International Medicine & Public Health Source Type: news
FDA Approves Bristol Myers Squibb ’s Zeposia (ozanimod), an Oral Treatment for Adults with Moderately to Severely Active Ulcerative Colitis
PRINCETON, N.J.--(BUSINESS WIRE) May 27, 2021 -- Bristol Myers Squibb (NYSE:BMY) today announced that the U.S. Food and Drug Administration (FDA) approved Zeposia (ozanimod) 0.92 mg for the treatment of adults with moderately to severely active... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - May 27, 2021 Category: Drugs & Pharmacology Source Type: news
Janssen Presents Results of First Head-to-Head Study of Biologic Therapies in Patients with Moderate to Severe Crohn ’s Disease
SPRING HOUSE, PENNSYLVANIA, May 23, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced efficacy and safety data for STELARA® (ustekinumab) in Crohn’s disease (CD) and ulcerative colitis (UC),1-4including data from the SEAVUE study, the first head-to-head study of biologic therapies in patients with CD, presented in a Clinical Science Late-Breaking Abstract Plenary session.1 SEAVUE data showed treatment with STELARA demonstrated high rates of clinical remission, corticosteroid-free remission, clinical response and endoscopic response through one year in biologic-naïve patients with mo...
Source: Johnson and Johnson - May 24, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
The 5 Goals of Colonoscopy in Ulcerative Colitis The 5 Goals of Colonoscopy in Ulcerative Colitis
Dr Stephen Hanauer remarks on ruling out mimics, establishing disease severity, surveilling for cancer, and other key reasons to perform routine colonoscopy.Medscape Gastroenterology (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - May 21, 2021 Category: Gastroenterology Tags: Gastroenterology Commentary Source Type: news
How Long Does an Ulcerative Colitis Flare-Up Last?
Title: How Long Does an Ulcerative Colitis Flare-Up Last?Category: Diseases and ConditionsCreated: 5/17/2021 12:00:00 AMLast Editorial Review: 5/17/2021 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - May 17, 2021 Category: Nutrition Source Type: news
What Are the First Symptoms of Ulcerative Colitis?
Title: What Are the First Symptoms of Ulcerative Colitis?Category: Diseases and ConditionsCreated: 5/14/2021 12:00:00 AMLast Editorial Review: 5/14/2021 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - May 14, 2021 Category: Nutrition Source Type: news
What Is the Best Medicine for Ulcerative Colitis?
Title: What Is the Best Medicine for Ulcerative Colitis?Category: Diseases and ConditionsCreated: 5/14/2021 12:00:00 AMLast Editorial Review: 5/14/2021 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - May 14, 2021 Category: Nutrition Source Type: news
